Home › Research › Prevention and risk
Association of Daily Step Count and Intensity With Incident Dementia in 78 430 Adults Living in the UK
Del Pozo Cruz B, Ahmadi M, Naismith SL, Stamatakis E. JAMA Neurology, 2022-10-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Results The study monitored 78 430 adults (mean [SD] age, 61.1 [7.9] years; 35 040 [44.7%] male and 43 390 [55.3%] female; 881 [1.1%] were Asian, 641 [0.8%] were Black, 427 [0.5%] were of mixed race, 75 852 [96.7%] were White, and 629 [0.8%] were of another, unspecified race) over a median (IQR) follow-up of 6.9 (6.4-7.5) years, 866 of whom developed dementia (mean [SD] age, 68.3 [5.6] years; 480 [55.4%] male and 386 [54.6%] female; 5 [0.6%] Asian, 6 [0.7%] Black, 4 [0.4%] mixed race, 821 [97.6%] White, and 6 [0.7%] other). Analyses revealed nonlinear associations between daily steps. Conclusions and relevance In this cohort study, a higher number of steps was associated with lower risk of all-cause dementia. The findings suggest that a dose of just under 10 000 steps per day may be optimally associated with a lower risk of dementia.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 78,430 participants. In 78,430 UK adults (mean age 61) followed for a median of 6.9 years, 866 developed dementia. Reported effect size: HR 0.49 (95% CI 0.39-0.62) at 9,826 steps/day vs lowest activity.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Del Pozo Cruz, B., Ahmadi, M., Naismith, S. L., & Stamatakis, E. (2022). Association of Daily Step Count and Intensity With Incident Dementia in 78 430 Adults Living in the UK. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2022.2672
Vancouver
Del Pozo Cruz B, Ahmadi M, Naismith SL, Stamatakis E. Association of Daily Step Count and Intensity With Incident Dementia in 78 430 Adults Living in the UK. JAMA Neurology. 2022. doi:10.1001/jamaneurol.2022.2672. PMID: 36066874.
BibTeX
@article{delpozocruz2022-36066874,
author = {Del Pozo Cruz, B. and Ahmadi, M. and Naismith, S. L. and Stamatakis, E.},
title = {{Association of Daily Step Count and Intensity With Incident Dementia in 78 430 Adults Living in the UK}},
journal = {JAMA Neurology},
year = {2022},
doi = {10.1001/jamaneurol.2022.2672},
pmid = {36066874},
url = {https://doi.org/10.1001/jamaneurol.2022.2672}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results The study monitored 78 430 adults (mean [SD] age, 61.1 [7.9] years; 35 040 [44.7%] male and 43 390 [55.3%] female; 881 [1.1%] were Asian, 641 [0.8%] were Black, 427 [0.5%] were of mixed race, 75 852 [96.7%] were White, and 629 [0.8%] were of another, unspecified race) over a median (IQR) follow-up of 6.9 (6.4-7.5) years, 866 of whom developed dementia (mean [SD] age, 68.3 [5.6] years; 480 [55.4%] male and 386 [54.6%] female; 5 [0.6%] Asian, 6 [0.7%] Black, 4 [0.4%] mixed race, 821 [97.6%] White, and 6 [0.7%] other).
- Analyses revealed nonlinear associations between daily steps.
- Conclusions and relevance In this cohort study, a higher number of steps was associated with lower risk of all-cause dementia.
- The findings suggest that a dose of just under 10 000 steps per day may be optimally associated with a lower risk of dementia.
Why it matters
In 78,430 UK adults (mean age 61) followed for a median of 6.9 years, 866 developed dementia. Taking more daily steps was associated with a lower risk of all-cause dementia, and the authors suggest that "just under 10 000 steps per day may be optimally associated" with that lower risk. The study is observational and 96.7% of participants were White, so it cannot show that walking prevents dementia or that the same holds for every group.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Study designcohort
- Participants78,430
- Effect sizeHR 0.49 (95% CI 0.39-0.62) at 9,826 steps/day vs lowest activity
- Evidence strengthModerate
Limitations
Observational with a single week of accelerometry; 96.7% white; a published erratum corrected the article; reverse causation possible despite excluding early cases.
How this study scored 70/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 69 of the 98 points we could judge it on, which is 70 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (JAMA Neurology) |
| Journal's citation record | 2 / 4 | JAMA Neurology: journal h-index 235 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 4 / 4 | 78,430 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 180 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 30.0 citations a year over 6 year(s) since 2022 |
| Impact for its field and year | 4 / 6 | Cited 18.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 7 other studies in this library |
| Still being cited | 3 / 4 | Cited 123 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Emmanuel Stamatakis: h-index 85 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | The University of Sydney: institution h-index 1,466 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 36066874) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 69 / 98 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 69 of the 98 points we could judge it on is 70 out of 100. |
| Total | 70 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/jamaneurol.2022.2672
- PubMed: 36066874
- Original source →
- Free full text: PubMed Central →
Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
7 studies in the alzhub library list this one in their references.
Related studies in Prevention and risk from nearby years
Also tagged “daily-steps-and-amyloid-positive-decline”
3 studies in the library carry the topic tag “daily-steps-and-amyloid-positive-decline”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 3 tagged studies.